Anti-GSK-3B monoclonal antibody
Pre-made anti-GSK-3B monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to GSK-3B/GSK3B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T70977-Ab-1/ GM-Tg-hg-T70977-Ab-2 | Anti-Human GSK-3B/GSK3B monoclonal antibody | Human |
GM-Tg-rg-T70977-Ab-1/ GM-Tg-rg-T70977-Ab-2 | Anti-Rat GSK-3B/GSK3B monoclonal antibody | Rat |
GM-Tg-mg-T70977-Ab-1/ GM-Tg-mg-T70977-Ab-2 | Anti-Mouse GSK-3B/GSK3B monoclonal antibody | Mouse |
GM-Tg-cynog-T70977-Ab-1/ GM-Tg-cynog-T70977-Ab-2 | Anti-Cynomolgus/ Rhesus macaque GSK-3B/GSK3B monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T70977-Ab-1/ GM-Tg-felg-T70977-Ab-2 | Anti-Feline GSK-3B/GSK3B monoclonal antibody | Feline |
GM-Tg-cang-T70977-Ab-1/ GM-Tg-cang-T70977-Ab-2 | Anti-Canine GSK-3B/GSK3B monoclonal antibody | Canine |
GM-Tg-bovg-T70977-Ab-1/ GM-Tg-bovg-T70977-Ab-2 | Anti-Bovine GSK-3B/GSK3B monoclonal antibody | Bovine |
GM-Tg-equg-T70977-Ab-1/ GM-Tg-equg-T70977-Ab-2 | Anti-Equine GSK-3B/GSK3B monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-T70977-Ab-1/ GM-Tg-hg-T70977-Ab-2; GM-Tg-rg-T70977-Ab-1/ GM-Tg-rg-T70977-Ab-2; GM-Tg-mg-T70977-Ab-1/ GM-Tg-mg-T70977-Ab-2; GM-Tg-cynog-T70977-Ab-1/ GM-Tg-cynog-T70977-Ab-2; GM-Tg-felg-T70977-Ab-1/ GM-Tg-felg-T70977-Ab-2; GM-Tg-cang-T70977-Ab-1/ GM-Tg-cang-T70977-Ab-2; GM-Tg-bovg-T70977-Ab-1/ GM-Tg-bovg-T70977-Ab-2; GM-Tg-equg-T70977-Ab-1/ GM-Tg-equg-T70977-Ab-2 |
Products Name | Anti-GSK-3B/GSK3B monoclonal antibody |
Format | mab |
Target Name | GSK-3B |
Protein Sub-location | Introcelluar Protein |
Category of antibody | Therapeutics Target antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-GSK-3B monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-T70977-Ag-1 | Recombinant multi-species GSK3B/ GSK-3B protein |
ORF Viral Vector | pGMAAV000150 | human GSK3B AAV plasmid |
ORF Viral Vector | vGMAAV000150 | human GSK3B AAV particle |
Target information
Target ID | GM-T70977 |
Target Name | GSK-3B |
Gene ID | 2932,56637,84027,713114,478575,101081660,790875,100061033 |
Gene Symbol and Synonyms | 7330414F15Rik,8430431H08Rik,GSK-3,GSK-3beta,GSK3,GSK3B,GSK3beta |
Uniprot Accession | P49841,P18266 |
Uniprot Entry Name | GSK3B_HUMAN,GSK3B_RAT |
Protein Sub-location | Introcelluar Protein |
Category | Therapeutics Target |
Disease | N/A |
Gene Ensembl | ENSG00000082701 |
Target Classification | Kinase |
The target: GSK-3B, gene name: GSK3B, also named as . The protein encoded by this gene is a serine-threonine kinase belonging to the glycogen synthase kinase subfamily. It is a negative regulator of glucose homeostasis and is involved in energy metabolism, inflammation, ER-stress, mitochondrial dysfunction, and apoptotic pathways. Defects in this gene have been associated with Parkinson disease and Alzheimer disease. [provided by RefSeq, Aug 2017].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.